Acceptance of Tamoxifen Chemoprevention by Physicians and Women at Risk Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Hormonal
  • Breast Neoplasms
  • Patient Acceptance of Health Care
  • Tamoxifen

abstract

  • In the current study, risk due to AH or LCIS was found to be the main predictor of being offered and accepting tamoxifen chemoprevention.

publication date

  • May 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.20205

PubMed ID

  • 15112259

Additional Document Info

start page

  • 1800

end page

  • 6

volume

  • 100

number

  • 9